[태그:] 건강

Technology Holdings (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftechnologyholdings.com%2F&esheet=53901632&newsitemid=20240226928319&lan=en-US&anchor=Technology+Holdings&index=1&md5=c10a262fc46f07408d5f60dbfc8fd353), a global investment bank with offices in North America, Europe and the Asia-Pacific, proudly announces the launch of TH Healthcare & Life Sciences, its specialist healthcare investment…

런던, 영국–(Business Wire / 뉴스와이어)–북미, 유럽, 아시아 태평양에 지사를 둔 글로벌 투자은행인 테크놀로지 홀딩스(Technology Holdings)가 헬스케어 전문 투자은행 사업부인 TH 헬스케어 & 라이프사이언스(TH Healthcare & Life Sciences)를 출범한다고 발표했다. TH…

Takeda (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2F&esheet=53901571&newsitemid=20240226565897&lan=en-US&anchor=Takeda&index=1&md5=66a3b376ad586d49f3651a4e8ba4fded) (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=53901571&newsitemid=20240226565897&lan=en-US&anchor=TSE%3A4502%2FNYSE%3ATAK&index=2&md5=330e6eb112da70d6ea46def0e3643fe6)) and Biological E. Limited (BE), a leading India-ba…

케임브리지, 매사추세츠 및 하이데라바드, 인도–(Business Wire / 뉴스와이어)–다케다(Takeda)(도쿄증권거래소: 4502/뉴욕증권거래소: TAK)와 인도의 선도적 백신 및 제약회사인 바이올로지컬 E(Biological E. Limited, BE)가 QDENGA®▽(뎅기 4가 백신)(TAK-003)의 다회용량바이알(MDV) 출시를 가속화하기 위한 전략적 파트너십을 체결했다고…

Galderma: Delivered against full year guidance for another consecutive year with strong financial performance · Galderma achieved net sales of 4.082 B USD, up 8.5% year-on-year on a constant currency…